Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
CLSDCompany Name
CLEARSIDE BIOMEDICAL INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCLEARSIDE BIOMEDICAL INC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CLSD - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 32M | $ -27.71M | 0 |
| 3/31/2025 | $ 67.18M | $ -30.81M | 0 |
| 12/31/2024 | $ 79.46M | $ -34.35M | 0 |
| 9/30/2024 | $ 84.19M | $ -31.88M | 0 |
| 6/30/2024 | $ 79.98M | $ -33.46M | 0 |
| 3/31/2024 | $ 93.41M | $ -34.97M | 0 |
| 12/31/2023 | $ 122.54M | $ -32.48M | 0 |
| 9/30/2023 | $ 60.54M | $ -37.32M | 0 |
| 6/30/2023 | $ 65.75M | $ -35.88M | 0 |
| 3/31/2023 | $ 64.75M | $ -34.58M | 0 |
Key Performance Insights, Last 5 Years
- CLEARSIDE BIOMEDICAL INC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, CLEARSIDE BIOMEDICAL INC's average P/E has been 646.77.
- The median P/E for CLEARSIDE BIOMEDICAL INC during this period was 646.77
- CLEARSIDE BIOMEDICAL INC reached its highest P/E over the past 5 years at 985.6.
- The lowest P/E recorded by CLEARSIDE BIOMEDICAL INC in the same timeframe 307.94
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for CLEARSIDE BIOMEDICAL INC is calculated as follows: Market Cap [ $ 73.98M ] / Net Inc. Cmn. [ $ -14.19M ]
(=) P/E [ 0 ] CLSD - Price to Earnings, Last 5 years
307.94
Minimum
Dec 31, 2021
985.6
Maximum
Mar 31, 2022
646.77
Average
646.77
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.52 with a standard deviation of 13.95.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.07K |
|---|---|
| min | 0.13 |
| max | 70.11 |
| average | 22.52 |
| median | 18.89 |
| std | 13.95 |